期刊文献+

Recent advances in bariatric/metabolic surgery:appraisal of clinical evidence 被引量:11

Recent advances in bariatric/metabolic surgery:appraisal of clinical evidence
下载PDF
导出
摘要 Obesity and associated type 2 diabetes mellitus(T2DM) are becoming a serious medical issue worldwide.Bariatric surgery has been shown to be the most effective and durable therapy for the treatment of morbid obese patients.Increasing data indicates bariatric surgery as metabolic surgery is an effective and novel therapy for not well controlled obese T2 DM patients.The review of recent developments in bariatric/metabolic surgery covers 4major fields.1) Improvement of safety:recent advances in laparoscopic/metabolic surgery has made this minimal invasive surgery more than ten times safer than a decade ago.The safety profile of laparoscopic/metabolic surgery is compatible with that of laparoscopic cholecystectomy now.2) New bariatric/metabolic surgery:laparoscopic sleeve gastrectomy(LSG) is becoming the leading bariatric surgery because of its simplicity and efficacy.Other new procedures,such as gastric plication,banded plication,single anastomosis(mini) gastric bypass and Duodeno-jejunal bypass with sleeve gastrectomy have all been accepted as treatment modalities for bariatric/metabolic surgery.3)Mechanism of bariatric/metabolic surgery:Restriction is the most important mechanism for bariatric surgery.Weight regain after bariatric surgery is usually associated with loss of restriction.Recent studies demonstrated that gut hormone,microbiota and bile acid changes after bariatric surgery may play an important role in durable weight loss as well as in T2 DM remission.However,weight loss is still the cornerstone of T2 DM remission after metabolic surgery.4) Patient selection:patients who may benefit most from bariatric surgery was found to be patients with insulin resistance.For Asian T2 DM patients,the indication of metabolic surgery has been set to those with not well2controlled(Hb A1 c.7.5%) disease and with their BMI.27.5 Kg/m.A novel diabetes surgical score,ABCD score,is a simple system for predicting the success of surgical therapy for T2 DM. Obesity and associated type 2 diabetes mellitus(T2DM) are becoming a serious medical issue worldwide.Bariatric surgery has been shown to be the most effective and durable therapy for the treatment of morbid obese patients.Increasing data indicates bariatric surgery as metabolic surgery is an effective and novel therapy for not well controlled obese T2 DM patients.The review of recent developments in bariatric/metabolic surgery covers 4major fields.1) Improvement of safety:recent advances in laparoscopic/metabolic surgery has made this minimal invasive surgery more than ten times safer than a decade ago.The safety profile of laparoscopic/metabolic surgery is compatible with that of laparoscopic cholecystectomy now.2) New bariatric/metabolic surgery:laparoscopic sleeve gastrectomy(LSG) is becoming the leading bariatric surgery because of its simplicity and efficacy.Other new procedures,such as gastric plication,banded plication,single anastomosis(mini) gastric bypass and Duodeno-jejunal bypass with sleeve gastrectomy have all been accepted as treatment modalities for bariatric/metabolic surgery.3)Mechanism of bariatric/metabolic surgery:Restriction is the most important mechanism for bariatric surgery.Weight regain after bariatric surgery is usually associated with loss of restriction.Recent studies demonstrated that gut hormone,microbiota and bile acid changes after bariatric surgery may play an important role in durable weight loss as well as in T2 DM remission.However,weight loss is still the cornerstone of T2 DM remission after metabolic surgery.4) Patient selection:patients who may benefit most from bariatric surgery was found to be patients with insulin resistance.For Asian T2 DM patients,the indication of metabolic surgery has been set to those with not well2controlled(Hb A1 c.7.5%) disease and with their BMI.27.5 Kg/m.A novel diabetes surgical score,ABCD score,is a simple system for predicting the success of surgical therapy for T2 DM.
机构地区 Department of Surgery
出处 《The Journal of Biomedical Research》 CAS CSCD 2015年第2期98-104,共7页 生物医学研究杂志(英文版)
关键词 bariatric surgery metabolic surgery type 2 diabetes mellitus ADVANCES bariatric surgery metabolic surgery type 2 diabetes mellitus advances
  • 相关文献

参考文献1

二级参考文献21

  • 1Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Dia- betes Surgery Summit consensus conference: recommenda- tions for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010; 251: 399-405.
  • 2Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Po- ries WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256.e5.
  • 3Lee WJ, Chong K, Lee YC, Ser KH, Chen SC, Chen JC, Peng WP, Chen CM. Effects of obesity surgery on type 2 diabetes mellitus Asian patients. World J Surg 2009; 33: 1895-1903.
  • 4Greenway SE, Greenway FL, Klein S. Effects of obesity sur- gery on non-insulin-dependent diabetes mellitus. Arch Surg 2002; 137: 1109-1117.
  • 5Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
  • 6Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas- Mitchel E, Rao RH, Kuller L, Kelley D. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484; discussion 484-485.
  • 7Sjstrm L, Lindroos AK, Peltonen M, Torgerson J, Boucha- rd C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjstrm CD, Sullivan M, Wedel H. Lifestyle, diabetes, and cardio- vascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.
  • 8Hickey MS, Pories WJ, MacDonald KG, Cory KA, DohmGL, Swanson MS, Israel RG, Barakat HA, Considine RV, Caro JF, Houmard JA. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut Ann Surg 1998; 227: 637-643; discussion 643-644.
  • 9Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554-559.
  • 10Rubino F. Is type 2 diabetes an operable intestinal disease A provocative yet reasonable hypothesis. Diabetes Care 2008; 31 Suppl 2: S290-S296.

共引文献17

同被引文献44

引证文献11

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部